Robotics Automation News
JANUARY 4, 2023
University College London (UCL) have developed an exciting new 3D printing technique: “volumetric 3D printing” that lets the pharmaceutical industry customize drugs – including shape, size, dosage, and release – according to each patient’s individual needs.
Additive Manufacturing
NOVEMBER 30, 2022
“We are excited to receive IND clearance to begin clinical trials of this potentially transformative treatment for patients, ” said Dr. With a unique 3D dosage form design, T21 can reach the targeted colon segment of the GI tract, thus permitting use of a lower drug dose than the reference listed drug, which provides systemic exposure.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AU Manufacturing
APRIL 19, 2023
During the event, slated to take place from 23 to 27 April, the institution will introduce breakthroughs that have broad implications and have the potential to speed up the development of drug delivery systems, biodegradable contact lenses, and pharmaceuticals. as a scientific highlight for the entire conference.
WORCON
JUNE 5, 2023
A team of scientists from the Max Planck Institute for Informatics in Saarbrücken, Germany, and the University of California at Davis, have developed a novel process for 3D printing pills that can release pharmaceutical drugs at predetermined speeds.
Additive Manufacturing
DECEMBER 5, 2022
Along with NASA invested in systems to use large-scale 3D printing to build lunar structures, the 3D printing community just can’t stop pushing the boundaries of what can be done. Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis : Triastek, Inc. ,
Additive Manufacturing
AUGUST 30, 2022
It is no surprise, then, that the company has invested heavily across the years in medical 3D printing technologies to research and develop new products and solutions. Again, looking at the customer base, we have a medical device customers, we have consumer customers and also the pharmaceutical side. Says Onukuri. Says Onukuri.
Additive Manufacturing
JULY 29, 2022
/July 28, 2022 — Redwire Corporation, solar power generation and in-space 3D printing company, announced it will be developing new in-space manufacturing technology to provide novel and flexible services to grow small-batch crystals of protein-based pharmaceuticals and other key pharmaceutically relevant molecules for research and production.
Expert insights. Personalized for you.
145 
Let's personalize your content